Cure Pharmaceutical Plans to Acquire Cannabinoid-Based Drug Pipeline from Therapix Biosciences Read more
Catalent Biologics Adopts Berkeley Lights’ Beacon Optofluidic Platform To Accelerate Cell Line Development Read more
Symphogen A/S and Selexis Expand Relationship as Symphogen Advances its Monoclonal Antibody (mAb) Mixture Pipeline Read more
BioCryst Pharmaceuticals Announces Termination of Merger Agreement with Idera Pharmaceuticals Read more